Submitted by Anonymous (not verified) on 20 October 2026 - 13:54
Human medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 30/03/2023, Revision: 17, Status: Authorised
Source: